LCB02A

· LigaChem Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCB02A, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors [Phase 1, Phase 2]